Small cap upscale apparel retailer Vince Holding Corp (NYSE: VNCE) recently had a spectacular IPO and while there aren�� any ETFs that track the luxury or upscale apparel or retail segments, the performance of large cap Michael Kors Holdings Ltd (NYSE: KORS), the last major apparel retail group to debut in the US IPO market, and Francesca's Holdings Corp (NASDAQ: FRAN), which debuted some months before KORS,�offer investors�good performance benchmarks for investors. But is Vince Holding Corp a bargain deal for investors?
What is Vince Holding Corp?Founded in 2002, Vince Holding Corp began with a collection of stylish women�� knits and cashmere sweaters but has since grown to include a men�� collection in 2007; expanded denim, leather and outerwear lines in 2010; and women�� footwear, which was launched through a licensing partnership in 2012. Vince Holding Corp says the Vince brand is ��ynonymous with a clean, timeless aesthetic, sophisticated design and superior quality��plus it�� a ��rominent fashion brand known for its modern effortless style and everyday luxury essentials.��Today, Vince Holding Corp offers a broad range of women�� and men�� ready-to-wear items (including signature cashmere sweaters, leather jackets, luxe leggings, dresses, silk and woven tops, denim and footwear) in over 2,100 stores across 43 countries and operates 21 full-price retail locations, 6 outlet stores and�an e-commerce site called�Vince.com.
Top 10 Forestry Stocks To Invest In Right Now: Affymax Inc.(AFFY)
Affymax, Inc., a biopharmaceutical company, engages in the development of drugs for the treatment of serious and life-threatening conditions. It develops peginesatide (Hematide), which has completed Phase III clinical trial for the treatment of anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. The company has strategic alliance agreements with Takeda Pharmaceutical Company Limited and Nektar Therapeutics AL, Corporation to develop and commercialize Hematide. Affymax, Inc. was founded in 2001 and is based in Palo Alto, California.
Advisors' Opinion:- [By Kanak Kanti De]
Amgen needed an Onyx-like acquisition badly. For one, sales of Aranesp and Epogen, its flagship drugs for anemia, are dropping on concerns of safety, and loss of monopoly in 2012 to Affymax (AFFY), which received FDA approval for a rival anemia drug. (Note though, that after Omontys was recalled this year, that problem is resolved for Amgen.) Secondly, four of its top selling products go off patent in 2015.
Top 10 Forestry Stocks To Invest In Right Now: Forbes Energy Services Ltd (FES)
Forbes Energy Services Ltd. (FES Ltd) is an independent oilfield services contractor that provides a range of well site services to oil and natural gas drilling and producing companies to help develop and enhance the production of oil and natural gas. These services include fluid hauling, fluid disposal, well maintenance, completion services, workovers and recompletions, plugging and abandonment, and tubing testing. FES Ltd operates in two segments: well servicing and fluid logistics and other. Its operations are concentrated in the onshore oil and natural gas producing regions of Texas, with additional locations in Mississippi, in Pennsylvania and, prior to the disposition of its Mexican assets in January 2012, which is discussed below, in Mexico. In January 2012, the Company sold its assets located in Mexico, as well as its equity interests in Forbes Energy Services Mexico Servicios de Personal, S. de R.L. de C.V. Advisors' Opinion:- [By CRWE]
Forbes Energy Services Ltd. (NASDAQ:FES), a leader in well servicing and fluid logistics management in the oilfield services industry, will participate in the GHS 100 Energy Conference being held June 25-26, 2012, at the Intercontinental Hotel in San Francisco.
Best Consumer Service Companies For 2015: Chatham Lodging Trust (CLDT)
Chatham Lodging Trust is a hotel investment company. The Company was formed to invest in extended-stay, select-service and full-service hotels. The Company focuses on investing in select-service hotels, such as Courtyard by Marriott, Hampton Inn and Hampton Inn and Suites. In addition, Chatham Lodging Trust focuses on investing in branded full-service hotels. In October 2011, the Company and affiliates of Cerberus Capital Management, L.P., acquired 64 hotels from affiliates of Innkeepers USA Trust. In June 2013, Chatham Lodging Trust announced that has completed its acquisition of the 178-room Hyatt Place Pittsburgh/North Shore in Pittsburgh, Pa. Effective August 13, 2013, Chatham Lodging Trust acquired Hampton Inn & Suites, an owner and operator of hotels. In October 2013, Chatham Lodging Trust acquired Hilton Garden Inn Denver Tech Center. In November 2013, Chatham Lodging Trust acquired the 231-room Residence Inn by Marriott Seattle Bellevue/Downtown. In December 2013, Chatham Lodging Trust acquired the 160-room SpringHill Suites by Marriott Savannah Downtown/Historic District.
The Company focuses on investing primarily in hotels in the metropolitan markets in the United States. The Company has not entered into any contracts to acquire hotel properties or other assets.
Advisors' Opinion:- [By , Zacks Investment Research]
Here are five�stocks that made it through this week’s screen:
AmTrust Financial (AFSI) Allied World Assurance (AWH) Chatham Lodging Trust (CLDT) Federated National Holding Co. (FNHC) Whitewave Foods (WWAV)Get the rest of the stocks on this list and start screening for these companies on your own.
- [By Rich Duprey]
Luxury, extended-stay hotel operator�Chatham Lodging Trust (NYSE: CLDT ) announced this morning�its dividend for the month of June of $0.07 per share, the same rate it's paid for the past five months after switching over to a monthly payment schedule.�
- [By Lauren Pollock]
Chatham Lodging Trust(CLDT) unveiled a plan to offer at least 3.3 million shares, as the real-estate investment trust looks to raise proceeds to repay debt and help fund a portion of a property acquisition in Bellevue, Wash. Shares slipped 5.4% to $18.35 premarket.
Top 10 Forestry Stocks To Invest In Right Now: Transmontaigne Partners L.P. (TLP)
TransMontaigne Partners L.P. operates as a terminaling and transportation company. It provides integrated terminaling, storage, transportation, and related services for customers engaged in the distribution and marketing of light refined petroleum products, heavy refined petroleum products, crude oil, chemicals, fertilizers, and other liquid products. The company operates along the Gulf Coast, in the Midwest, in Brownsville, Texas, along the Mississippi and Ohio Rivers, and in the southeastern United States. As of December 31, 2010, it operated 7 refined product terminals in Florida with an aggregate storage capacity of approximately 7.1 million barrels; a 67-mile interstate refined products pipeline between Missouri and Arkansas and 3 refined product terminals with approximately 0.6 million barrels of aggregate active storage capacity; 2 refined product terminals located in Mt. Vernon, Missouri, as well as Rogers, Arkansas with an aggregate active storage capacity of appr oximately 407,000 barrels; and 1 refined product terminal in Oklahoma City, Oklahoma with an aggregate active storage capacity of approximately 158,000 barrels. The company also operated 1 refined product terminal in Brownsville, Texas with an aggregate active storage capacity of approximately 2.2 million barrels; 1 refined product terminal located in Matamoros, Mexico with an aggregate active LPG storage capacity of approximately 7,000 barrels; a pipeline from Brownsville facilities to its terminal in Matamoros, Mexico; 12 refined product terminals along the Mississippi and Ohio rivers with an aggregate active storage capacity of approximately 2.5 million barrels, as well as a dock facility; and 22 refined product terminals along the Colonial and Plantation pipelines with an aggregate active storage capacity of approximately 9.3 million barrels. TransMontaigne GP L.L.C. serves as the general partner of the company. TransMontaigne Partners L.P. was founded in 2005 and is bas ed in Denver, Colorado.
Advisors' Opinion:- [By Eric Volkman]
TransMontaigne Partners (NYSE: TLP ) is drilling into the market to raise in the neighborhood of $60 million. The company has floated 1.45 million of its common units in an underwritten public offering priced at $43.32 per unit. The company's underwriters have also been granted a 30-day purchase option for up to an additional 217,500 units.
- [By Seth Jayson]
Transmontaigne Partners (NYSE: TLP ) is expected to report Q2 earnings around July 16. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Transmontaigne Partners's revenues will increase 5.5% and EPS will compress -23.9%. - [By Eric Volkman]
TransMontaigne Partners (NYSE: TLP ) is about to ship a bigger load of dividend to its unit holders. The company has declared a new distribution of $0.65 per unit, to be dispensed on Aug. 8 to holders of record as of July 31.That amount is $0.01, or 1.6%, higher than the company's previous payout of $0.64. It had distributed this amount in each of the preceding four quarters.
Top 10 Forestry Stocks To Invest In Right Now: Perrigo Company PLC (PRGO)
Perrigo Company plc, incorporated on March 23, 1988, is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri. The Company�� businesses include Consumer Healthcare, Nutritionals, Rx Pharmaceuticals, API, Life Sciences and Other Businesses. The Company offers Healthcare Products across a range of product categories primarily in the United States, the United Kingdom, Mexico, Israel and Australia, and distributes into dozens of other markets worldwide, including Canada, China and Latin America. In February 2014, the Company announced that it has acquired a basket of value-brand OTC products sold in Australia and New Zealand from Aspen Global Inc.
The Company operates through several wholly owned subsidiaries. In the United States, its operations are conducted primarily through L. Perrigo Company, Perrigo Company of South Carolina, Inc., Perrigo New York, Inc., PBM Products, LLC, PBM Nutritionals, LLC, Paddock Laboratories, LLC, Perrigo Diabetes Care, LLC (formerly CanAm Care, LLC), Sergeant's Pet Care Products, Inc. and Fidopharm, Inc. Outside the United States, its operations are conducted primarily through Perrigo Israel Pharmaceuticals Ltd., Chemagis Ltd., Quimica y Farmacia S.A. de C.V., Laboratorios Diba, S.A., Wrafton Laboratories Limited, Galpharm Healthcare Ltd., Orion Laboratories Pty Ltd and Rosemont Pharmaceuticals Ltd.
Consumer Healthcare
Perrigo Consumer Healthcare (CHC) operation includes the Company's United States, United Kingdom and Mexico manufacturing operations supporting the sale of OTC pharmaceutical products. Perrigo CHC supplies more than 15 categories and 500 formulas and offers analgesics, cough and cold remedies, and gastrointestinal and feminine hygiene products, as w! ell as vitamins, dietary supplements and nutritional drinks. Perrigo offers a range of products, such advertised brand products as Tylenol, Advil or One-A-Day. Tylenol has acetaminophen as an active ingredient and is available in stores' analgesic (pain reliever) aisle. Store-brand acetaminophen is located next to the national brand, offering the same active ingredient (acetaminophen) and the same pain relief.
Perrigo Nutritionals
Perrigo is a manufacturer of nutrition products for the store brand market. Nutrition products include infant formula, pediatric nutritionals and vitamins, minerals, and supplements. Acquired by Perrigo, Perrigo Nutritionals, formerly PBM Products, LLC, had introduced private-label, or store-brand infant formulas to the United States. Perrigo Nutritionals is the supplier of store-brand infant formulas and nutrition products. With distribution to major retailers, Perrigo Nutritional products can be found in more than 40,000 retail locations around the world. Its pediatric nutritionals business extends its offerings to children well beyond infancy. Its baby cereals, toddler foods, and pediatric nutritional drinks are available as store brands at various retail locations throughout the United States and the international community. Perrigo manufactures a range of vitamins, minerals, and supplements, in every major segment of the business. Marketed under the store brand labels of the retailers in the food, drug, mass-merchandise and wholesale club channels, it manufactures over 395 formulas of dietary supplements. Its brands include Centrum, One-A-Day, Flintstones, and Osteo-Bi-Flex.
Rx Pharmaceuticals
The Company�� Rx Pharmaceuticals business is focused on the development, manufacture and sale of generic prescription drug products, primarily for the United States market. Manufacturing operations are based in the United States and Israel. Perrigo's portfolio focuses on complex, high-barrier ophthalmological, topical foam and or! al liquid! formulations. Its products include Acetylcysteine Injection 200 mg/mL (6g/30mL), Acetylcysteine Injection 6 g/30 mL (200 mg/1 mL), NOVAPLUS, ACTIDOSE with SORBITOL, ACTIDOSE-AQUA, ASPIRIN SUPPOSITORIES USP, Bacitracin Ophthalmic Ointment USP, Belladonna and Opium Suppositories C-II, BENZOIN COMPOUND TINCTURE USP, Benzoyl Peroxide 10% Acne Medication Wash, CLOBETASOL PROPIONATE LOTION 0.05% and Docusate Sodium.
Active Pharmaceutical Ingredients
Primarily through the Company�� Israel-based business, Perrigo develops, manufactures and markets the complex chemicals and active pharmaceutical ingredients used worldwide by the generic drug industry. Certain of these ingredients are also used in Perrigo's own pharmaceutical products. It manufactures API at facilities in Israel, India and China. Perrigo API specializes in tailor-made research and process development of APIs and Finished Dosage Forms (FDFs).
Life Sciences
Through the Company�� Israel-based business, Perrigo markets and manufactures branded prescription drugs and medical diagnostic products through exclusive agreements with pharmaceutical companies. Its Pharmaceutical and Medical Diagnostic Products businesses also market and manufacture branded prescription drugs under licenses. Other pharmaceutical and medical diagnostics products are imported to Israel through exclusive agreements. Products in life sciences segment include TYSABRI and ELND005. TYSABRI (natalizumab) is indicated for treatment of: Multiple Sclerosis: as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. TYSABRI is recommended for patients who have had an inadequate response to, or are unable to tolerate, an alternate MS therapy; Crohn�� Disease (CD): Inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn�� disease with e! vidence o! f inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of tumor necrosis factor-伪.
Other
Perrigo's Pharmaceutical and Medical Diagnostic Products business markets and manufactures branded prescription drugs under licenses. Other pharmaceutical and medical diagnostic products are imported to Israel through exclusive agreements with pharmaceutical and diagnostics companies. This business is divided into two departments: Pharma-Israel and Tayco Diagnostics. Pharma-Israel operates in the Israeli market as a partner in the marketing, sales and distribution of Rx (dermatology, gastroenterology, blood products, CNS, urology and other fields), OTC, generics, branded generics, dermo-cosmetics and dietary supplements. Tayco, the diagnostics division of Perrigo-Israel Pharmaceuticals Ltd., specializes in marketing and sales of medical laboratory systems, reagents, accessories and consumables. It also markets self-monitoring medical devices for diagnosis and treatment of diabetes. The division operates throughout Israel to service the central laboratory, hospital, clinic, point of care and self-testing markets. Its activities in the medical and research fields in Israel cover all market segments: medical (private and public health services), research institutions and the biotech industry.
The Company competes with Dr. Reddy�� Laboratories, Ltd., Actavis Inc., Aaron Industries, Inc., Ohm Laboratories, Inc., PL Developments, LNK International, Inc., Abbott Laboratories, Mead Johnson Nutrition Co., Nestle S.A. (Gerber), Danone Baby Nutrition, Bayer AG, Pfizer, Inc., Rexall Sundown, Inc., Apotex, Glenmark Generics Inc., Impax, Prasco, Sandoz, Taro Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Triax Pharmaceuticals, and Zydus Pharmaceuticals.
Advisors' Opinion:- [By Rich Duprey]
Investors going with health-care products maker Perrigo� (NYSE: PRGO ) �will receive a�quarterly cash dividend�of�$0.09 per share on June 18 to shareholders of record at the close of business on May 31 for the fiscal third quarter of 2013.
- [By Laura Brodbeck]
Stocks moving in the pre-market included:
Wyndham Worldwide Corp (NYSE: WYN) gained 2.65 percent in pre-market trade, adding to its 4.02 percent rise over the past five days. Goldman Sachs Group Inc (NYSE: GS) gained 1.42 percent in pre-market trade after falling 0.95 percent on Wednesday. Perrigo Co (NYSE: PRGO) gained 0.66 percent in pre-market trade after losing 1.96 percent in the past week. U.S. Bancorp (NYSE: USB) lost 0.61 percent in pre-market trade after gaining 0.80 percent over the past five days.Earnings
- [By Johnson Research Group]
Expect to see the shorts��resolve start to break as CERN stock cracks the $60 level, sparking a short squeeze.
Short Squeeze Candidate #2: Perrigo (PRGO)
Click to Enlarge Another classic setup for a short squeeze is the activity that we��e seeing in Perrigo (PRGO).
Top 10 Forestry Stocks To Invest In Right Now: Triangle Energy(global)
Triangle Energy (Global) Limited engages in the exploration and production of gas primarily in Indonesia. The company holds a 100% working interest in the production sharing contract of the Pase Block consisting of 3 production wells covering an area of approximately 922 square kilometers located in Aceh province, north Sumatra, Indonesia. It also holds a 20% interest in Reid?s Dome gas field, which covers an area of 181 square kilometers located in the Bowen Basin, Queensland. The company is based in Cottesloe, Australia.
Advisors' Opinion:- [By Fiona MacDonald]
��eople are optimistic and believe the government will do something with the development plan,��Fouad Darwish, head of brokerage at Kuwait-based Global Investment House KSCC (GLOBAL), said by phone. ��he optimism is so strong that people even ignored the fact that many companies didn�� announce their results on time, which usually led to selling off.��
Top 10 Forestry Stocks To Invest In Right Now: Teva Pharmaceutical Industries Limited (TEVA)
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. The company?s provides generic drug portfolio of approximately 1,450 molecules and a direct presence in 60 countries. It offers generic pharmaceutical products in a range of dosage forms, such as tablets, capsules, ointments, creams, liquids, injectables, and inhalants. The company sells its generic injectable products to hospitals, clinics, and other institutional channels, primarily in the United States and Europe, as well as in Latin America and eastern Europe. Its branded products include Copaxone to treat multiple sclerosis; and Azilect to treat Parkinson?s disease, as well as biosimilars, respiratory, and women?s health products. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.
Advisors' Opinion:- [By Keith Speights]
Any worries that Teva Pharmaceuticals (NYSE: TEVA ) might be able to challenge Gilead in the near future were allayed in February, so that's not a pressing concern for now. The two companies settled litigation that allows Teva to begin marketing a generic rival to Gilead's HIV drug on Dec. 15, 2017.
- [By Sean Williams]
Bipolar disorder is the final mood disorder characterized by major shifts in mood, energy, and ability to function, and it affects roughly 6 million people in the United States. Similar to dysthymia, medication and counseling are the two most common therapies used to keep this long-term disease in check. Perhaps one of the best-known treatments is Johnson & Johnson's�Risperdal, which has long since gone to a generic form and is now manufactured by Teva Pharmaceutical (NYSE: TEVA ) .�
- [By Lauren Pollock var popups = dojo.query(".socialByline .popC"); popups.forEach]
Teva Pharmaceutical Industries Ltd.(TEVA) and OncoGenex Pharmaceuticals Inc.(OGXI) said their experimental drug for hard-to-treat cases of prostate cancer didn’t result in statistically significant improvement in overall survival in a Phase 3 study. OncoGenex shares dropped 48% to $5 premarket.
- [By Sean Williams]
Teva brings out the ax
Becoming the latest large biopharmaceutical company to dramatically trim its workforce, on Thursday Teva Pharmaceutical (NYSE: TEVA ) announced that it'd be shedding 5,000 of its 46,000 global employees in an effort to save $2 billion annually by 2017. Teva plans to use its saved cash to reinvest in its R&D pipeline with a specific focus on complex generic drugs and specialty branded pharmaceutical products. In addition, it also plans to focus on emerging markets which should help it cope with the upcoming loss of Copaxone to generic competition. Copaxone, a multiple sclerosis blockbuster, currently accounts for close to one-fifth of Teva's revenue. This looks like a necessary move for the company, but it could lead to shaky growth over the next couple of quarters as it transitions.
Top 10 Forestry Stocks To Invest In Right Now: Pacer International Inc.(PACR)
Pacer International, Inc., together with its subsidiaries, provides asset-light transportation and logistics services primarily in North America, Asia, Europe, Australia, South America, and Africa. It operates in two segments, Intermodal and Logistics. The Intermodal segment offers intermodal rail transportation, local cartage and trucking, intermodal marketing services, container capacity, on-site operational services, and door-to-door shipment management services. As of December 31, 2011, its equipment fleet consisted of 1,592 double-stack railcars, 18,183 containers, and 12,783 chassis. The Logistics segment provides highway brokerage, warehousing and distribution, international freight forwarding, ocean and air shipping, and supply chain management services, as well as offers non-vessel-operating common carrier to end-user customers. The company markets and supports its services to cargo owners, steamship lines, truckload carriers, truck brokers, and freight forwarders , as well as other third party transportation service providers, such as intermodal marketing companies, third-party logistics companies, and shippers? agents through its direct sales and customer service representatives. Pacer International, Inc. was founded in 1974 and is headquartered in Dublin, Ohio.
Advisors' Opinion:- [By Jake L'Ecuyer]
XPO Logistics (NYSE: XPO) shot up 7.06 percent to $30.01 after the company announced its plans to acquire Pacer International (NASDAQ: PACR) in a deal valued at $335 million.
Top 10 Forestry Stocks To Invest In Right Now: LTX-Credence Corporation(LTXC)
LTX-Credence Corporation designs, manufactures, markets, and services automated test equipment solutions for the wireless, computing, automotive, and consumer markets. The company?s product portfolio includes Diamond platform, a package for testing microcontrollers and cost sensitive consumer devices; X-Series platform that offers configurations for optimal testing of ASSP and ASIC, power, automotive, mixed signal, and RF applications; and ASL platform, which is used for testing linear, low-end mixed signal, precision analog, and power management devices. The company also provides various services, including installation and maintenance of test systems, servicing of spare parts, parts and labor warranties on test systems, and training on the maintenance and operation of test systems. LTX-Credence Corporation sells its products through direct sales organization and distributors in the United States, Taiwan, China, Japan, Korea, and southeast Asia. The company was founded i n 1976 and is headquartered in Norwood, Massachusetts.
Advisors' Opinion:- [By CRWE]
LTX-Credence Corporation (Nasdaq:LTXC), a global provider of market focused, cost-optimized ATE solutions, reported that it will present at the Barclays Capital Global Technology, Media and Telecommunications Conference on Wednesday, May 23, 2012 at 4:15 PM EDT. This event will be available over the Internet via live webcast.
Top 10 Forestry Stocks To Invest In Right Now: Solta Medical Inc(SLTM)
Solta Medical, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system for patients who want to take control of their aging process. The company also provides Thermage CPT system that provides non-invasive treatment options for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the tre atment of mild-to-moderate inflammatory acne, including pustular acne. Its customers principally include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. The company sells its products primarily through a direct sales force, as well as through independent distributors; and CLARO device through retail and associated retailer?s Websites, and television retail networks, as well as through its own website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.
Advisors' Opinion:- [By Tess Stynes]
Among the companies with shares expected to actively trade in Monday’s session are Sprint Corp.(S), American International Group Inc.(AIG)�and Solta Medical Inc.(SLTM)
- [By John Udovich]
On Tuesday, small cap biotech stock Kythera Biopharmaceuticals Inc (NASDAQ: KYTH) surged around 25% after announcing that its ATX-101 REFINE-1 and REFINE-2 Phase III trials met all primary and secondary endpoints for the reduction of so-called double chins; but if investors missed out on that rally, small caps Zeltiq Aesthetics Inc (NASDAQ: ZLTQ), Solta Medical Inc (NASDAQ: SLTM) and Cynosure, Inc (NASDAQ: CYNO) each have a piece of the aesthetic market as well. In the case of Kythera Biopharmaceuticals, its ATX-101 can be injected to deal with double chins���meaning its less invasive than liposuction as the drug dissolves fat cells but leaves other tissue alone. JP Morgan has noted:
No comments:
Post a Comment